Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mivacurium in special patient groups

R M Jones1

  • 1St Mary's Hospital Medical School, London, UK.

Acta Anaesthesiologica Scandinavica. Supplementum
|January 1, 1995
PubMed
Summary

Mivacurium dosing varies significantly in special patient populations, including children, the elderly, and those with renal or hepatic impairment. Careful monitoring ensures safe use of this neuromuscular blocking agent in diverse patient groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CERN-based experiments and Monte-Carlo studies on focused dose delivery with very high energy electron (VHEE) beams for radiotherapy applications.

Scientific reports·2024
Same author

Alanine response to low energy synchrotron x-ray radiation.

Physics in medicine and biology·2023
Same author

Making copper, silver and gold fullerene cages breathe.

Journal of physics. Condensed matter : an Institute of Physics journal·2022
Same author

Focused VHEE (very high energy electron) beams and dose delivery for radiotherapy applications.

Scientific reports·2021
Same author

Quality and safety taken out of our hands?

Anaesthesia·2021
Same author

Safety, quality and efficiency of intra-operative imaging for treatment decisions in patients with suspected choledocholithiasis without pre-operative magnetic resonance cholangiopancreatography.

Surgical endoscopy·2021

Area of Science:

  • Pharmacology
  • Anesthesiology
  • Clinical Pharmacy

Background:

  • Drug response can differ in special patient groups compared to healthy adults.
  • Mivacurium is a neuromuscular blocking agent whose dosage may be affected by patient-specific factors.

Purpose of the Study:

  • To review the variable dose requirements of mivacurium in special patient groups.
  • To highlight the importance of monitoring drug effect in these populations.

Main Methods:

  • Review of existing literature on mivacurium pharmacokinetics and pharmacodynamics.
  • Analysis of factors influencing mivacurium dose requirements, including age, renal function, and hepatic function.

Main Results:

  • Children generally require larger mivacurium doses, while the elderly often need smaller doses.
  • Neonatal dose requirements may not significantly differ from adults.
  • Reduced plasma cholinesterase activity in patients with renal or severe liver disease necessitates smaller mivacurium doses.

Conclusions:

  • Mivacurium dosage must be adjusted based on patient age, renal, and hepatic status.
  • Appropriate monitoring of the neuromuscular block is crucial for safe mivacurium administration in special populations.
  • With careful consideration of dose variations, mivacurium can be safely used in pediatric, elderly, and renally or hepatically impaired patients.

Related Experiment Videos